JPMorgan Chase & Co’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-140,680
| Closed | -$520K | – | 4494 |
|
|
2016
Q1 | $520K | Buy |
140,680
+7,826
| +6% | +$28.9K | ﹤0.01% | 2897 |
|
|
2015
Q4 | $1.34M | Buy |
+132,854
| New | +$1.34M | ﹤0.01% | 2561 |
|
|
2015
Q2 | – | Sell |
-459,853
| Closed | -$12M | – | 3610 |
|
|
2015
Q1 | $12M | Buy |
459,853
+89,642
| +24% | +$2.35M | ﹤0.01% | 1619 |
|
|
2014
Q4 | $7.75M | Sell |
370,211
-1,394,854
| -79% | -$29.2M | ﹤0.01% | 1824 |
|
|
2014
Q3 | $58.9M | Sell |
1,765,065
-175,556
| -9% | -$5.86M | 0.01% | 755 |
|
|
2014
Q2 | $62.3M | Sell |
1,940,621
-525,302
| -21% | -$16.9M | 0.02% | 736 |
|
|
2014
Q1 | $114M | Buy |
2,465,923
+650,966
| +36% | +$30.1M | 0.03% | 500 |
|
|
2013
Q4 | $129M | Buy |
1,814,957
+143,824
| +9% | +$10.2M | 0.04% | 435 |
|
|
2013
Q3 | $143M | Buy |
1,671,133
+37,368
| +2% | +$3.2M | 0.04% | 414 |
|
|
2013
Q2 | $103M | Buy |
+1,633,765
| New | +$103M | 0.03% | 476 |
|